Devleela Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.80 M
- Revenue Growth %
- Net Worth 4777.40%
- Total Assets 4852.54%
About Devleela Lifesciences
Devleela Lifesciences Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 September 2013 and has a history of 11 years and four months. Its registered office is in Raipur, Chattisgarh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.80 M.
Rajendra Surana, Piyush Surana, and Rajdev Surana serve as directors at the Company.
Company Details
-
Location
Raipur, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100CT2013PTC001052
-
Company No.
001052
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Sep 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
Who are the key members and board of directors at Devleela Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Surana
|
Director | 04-Sep-2013 | Current |
|
Piyush Surana
|
Director | 04-Sep-2013 | Current |
|
Rajdev Surana
|
Director | 16-Jul-2015 | Current |
Financial Performance of Devleela Lifesciences.
Devleela Lifesciences Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 4777.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devleela Lifesciences?
In 2017, Devleela Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Leeladevi Agro Private LimitedRajendra Surana, Piyush Surana and 1 more are mutual person
Charges (Loans)
₹3.80 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Mar 2016 | Bank Of Baroda | ₹3.80 M | Open |
How Many Employees Work at Devleela Lifesciences?
Unlock and access historical data on people associated with Devleela Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devleela Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devleela Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.